Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Vitrectomy | Case report

Indirect choroidal neovascularization secondary to a posterior-segment intraocular foreign body – case report

Authors: Yu-Shiuan Lin, Kai-Ling Peng

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

We reported a rare case of indirect choroidal neovascularization (CNV) secondary to a posterior-segment intraocular foreign body (IOFB) that was not located in the area of direct injury but in the fovea. After intravitreal injections (IVIs) of aflibercept, the choroidal neovascularization (CNV) lesion disappeared and vision improved.

Case presentation

A 26-year-old male patient suffered from a fast-shot metallic IOFB in his right eye. He underwent primary corneal repair, pars plana vitrectomy, IOFB removal and an IVI of antibiotics in the right eye. Two weeks later, cataract surgery was performed on the right eye for traumatic cataract after an episode of acute phacolytic glaucoma. The best-corrected visual acuity (BCVA) of the right eye improved to 20/20 5 months after the first surgery. However, the vision of the right eye worsened suddenly with metamorphopsia 1 year after the first surgery. Color fundus images showed a whitish lesion with faint retinal hemorrhage and surrounding sensory elevation. Fluorescein angiography (FA) revealed a lesion with early- and late-phase severe leakage. Optical coherence tomography (OCT) demonstrated a CNV lesion with surrounding subretinal fluid. The patient received an IVI of aflibercept every 8 weeks for 3 times. Finally, the BCVA of the right eye improved to 20/25.

Conclusions

For rare cases of fovea-spared injury by a metallic IOFB, it is still necessary to pay close attention to the foveal microstructure to avoid possible CNV formation. Treatment with IVIs of anti-VEGF, aflibercept, as early as possible could provide good visual outcomes.
Literature
1.
go back to reference Ament CS, Zacks DN, Lane AM, et al. Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol. 2006;124:957–66.CrossRef Ament CS, Zacks DN, Lane AM, et al. Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol. 2006;124:957–66.CrossRef
3.
go back to reference Delori F, Pomerantzeff O, Cox MS. Deformation of the globe under high-speed impact: its relation to contusion injuries. Investig Ophthalmol. 1969;8(3):290–301 PMID: 5772720. Delori F, Pomerantzeff O, Cox MS. Deformation of the globe under high-speed impact: its relation to contusion injuries. Investig Ophthalmol. 1969;8(3):290–301 PMID: 5772720.
4.
go back to reference Kent D, Sheridan C. Choroidal neovascularization: a wound healing perspective. Mol Vis. 2003;22:747–55. Kent D, Sheridan C. Choroidal neovascularization: a wound healing perspective. Mol Vis. 2003;22:747–55.
6.
go back to reference Shocket SS, Lakhanpal V, Varma SD. Siderosis from a retained intraocular stone. Retina. 1981;1(3):201–7.CrossRef Shocket SS, Lakhanpal V, Varma SD. Siderosis from a retained intraocular stone. Retina. 1981;1(3):201–7.CrossRef
7.
go back to reference Chen TL, Sun MH, Lin KK, Lai CC, Chen KJ. Intravitreal bevacizumab with regression of subretinal neovascularization after intraocular foreign body trauma. J Trauma. 2010;68:747.CrossRef Chen TL, Sun MH, Lin KK, Lai CC, Chen KJ. Intravitreal bevacizumab with regression of subretinal neovascularization after intraocular foreign body trauma. J Trauma. 2010;68:747.CrossRef
8.
go back to reference Fernández-López E, Desco-Esteban MC, Fandiño-López A, Hernández-Díaz M, Navea A. Choroidal neovascularization after intraocular foreign body. Clin Ophthalmol. 2014;8:945–8.CrossRef Fernández-López E, Desco-Esteban MC, Fandiño-López A, Hernández-Díaz M, Navea A. Choroidal neovascularization after intraocular foreign body. Clin Ophthalmol. 2014;8:945–8.CrossRef
9.
go back to reference Liang F, Puche N, Soubrane G, Souied EH. Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture. Graefes Arch Clin Exp Ophthalmol. 2009;247:1285–8.CrossRef Liang F, Puche N, Soubrane G, Souied EH. Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture. Graefes Arch Clin Exp Ophthalmol. 2009;247:1285–8.CrossRef
10.
go back to reference Fauser S, Schwabecker V, Muether PS. Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration. Am J Ophthalmol. 2014;158:532–6.CrossRef Fauser S, Schwabecker V, Muether PS. Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration. Am J Ophthalmol. 2014;158:532–6.CrossRef
Metadata
Title
Indirect choroidal neovascularization secondary to a posterior-segment intraocular foreign body – case report
Authors
Yu-Shiuan Lin
Kai-Ling Peng
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01437-6

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue